Clinical trial
Navistar Thermocool Evaluation of the Catheter With the Stockert 70 Radiofrequency Generator for Endocardial Ablation in Patients With Typical Atrial Flutter
NCT00318565 is registered in ClinicalTrials.gov with Biosense Webster, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Navistar Thermocool Evaluation of the Catheter With the Stockert 70 Radiofrequency Generator for Endocardial Ablation in Patients With Typical Atrial Flutter
- Lead sponsor
- Biosense Webster, Inc.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2006
- Completion date
- February 29, 2008
- Enrollment
- 291 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.